Xspray Pharma
Xspray Pharma: HyNap-Dasa 505(b)(2) has reached BE (Redeye)
2021-07-29 15:31
Redeye leaves a comment on Xspray following the announcement that its HyNap-Dasa 505(b)(2) reached bioequivalence compared to its reference drug Sprycel. We raise our Base Case.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se